Taiwan FDA registration 9d34049d7c583ccd426393b116c0da47

Cimosir Rivaroxaban correction liquid and quality control liquid

TW: 希摩西爾Rivaroxaban校正液及品管液

Taiwan·Risk Class 2·INSTRUMENTATION LABORATORY CO.·Registered May 16, 2018 – May 16, 2028Active

Registration details

Analysis ID: 9d34049d7c583ccd426393b116c0da47
Customs Code: DHA05603111404

Company information

Manufacturer: INSTRUMENTATION LABORATORY CO.
Manufacturer Country: United States
Authorized Representative: Werfen Taiwan Limited

Product details

Intended Use: This product is suitable for calibration and quality control when measuring Rivaroxaban in the Liquid Anti-Xa test of ACL TOP Family.
Product Type (Level 1): A Clinical chemistry and clinical toxicology
Product Type (Level 2): A.1150 calibration;; A.1660 Quality control materials (analytical and non-analytical)
Import Information: import

Dates and status

Registration Date: May 16, 2018
Expiry Date: May 16, 2028

About this record

Access comprehensive regulatory information for Cimosir Rivaroxaban correction liquid and quality control liquid in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 9d34049d7c583ccd426393b116c0da47 and manufactured by INSTRUMENTATION LABORATORY CO.. The authorized representative in Taiwan is Werfen Taiwan Limited.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.